Science
Mechanism of Action
This ingredient functions as a Transient Receptor Potential Vanilloid 1 (TRPV1) antagonist. While standard capsaicin triggers heat and irritation, this derivative blocks the TRPV1 receptor to prevent the release of inflammatory neuropeptides like substance P and CGRP, effectively 'muting' the skin's response to external triggers of burning, itching, and redness.
Research
Clinical Evidence
High confidence5%
Key findings
- 01 Significant reduction in neurogenic inflammation and stinging sensations during capsaicin-challenge tests as documented in Helix BioMedix technical data and Patent US 8,969,298.
Transparency
Dusting Analysis
Clinical efficacy for neuro-soothing and TRPV1 antagonism is specifically benchmarked at 2.5% to 5.0%. Formulations utilizing this ingredient at levels below 1.0% are likely leveraging the name for marketing purposes rather than delivering therapeutic desensitization.
The Formula
Formulation
Stability
Highly thermolabile; it must be processed during the cool-down phase of formulation at temperatures under 40°C to maintain peptide integrity.
Synergies
- Ceramides
- Centella Asiatica
- Panthenol
- Glycerin
Conflicts
- Strong oxidizing agents
- Proteolytic enzymes
- Extreme pH environments
Safety
Safety Profile
While the specific conjugate is unreviewed by the CIR, its parent peptide Tripeptide-7 and similar derivatives are established as safe in concentrations typical of high-performance skincare.
Your Skin
Skin Compatibility
Our Assessment
Verdict
An elite neuro-cosmetic ingredient that provides precision relief for hyper-sensitive and stinging-prone skin when formulated at concentrations above 2.5%.
Related
Similar Ingredients
Finding similar ingredients…